Antisense nucleic acid targeting PCSK9
US-12544449-B2 · Feb 10, 2026 · US
This page is not indexed by search engines while we improve data quality.
TACHIBANA Keisuke patents
TACHIBANA Keisuke is listed as an inventor on 6 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | TACHIBANA Keisuke |
| Total patents | 6 |
| First publication | Jun 10, 2021 |
| Latest publication | Feb 10, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Test for mild cognitive impairment
US-2024142471-A1 · May 2, 2024 · US
Antisense nucleic acid targeting apoc3
US-2023113556-A1 · Apr 13, 2023 · US
Antisense nucleic acid targeting pcsk9
US-2022160880-A1 · May 26, 2022 · US
Antisense nucleic acid targeting PCSK9
US-11273222-B2 · Mar 15, 2022 · US
Antisense nucleic acid targeting pcsk9
US-2021170032-A1 · Jun 10, 2021 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Nat Cerebral & Cardiovascular Ct | 5 |
| Univ Osaka | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N2310/315 | 5 |
| C12N2310/3231 | 5 |
| C12N2310/11 | 5 |
| C12N2310/341 | 5 |
| A61P3/06 | 5 |